Hoan My Medical Group drives breast cancer diagnostics and treatment

The event, centring on the early diagnosis and comprehensive treatment of breast cancer, brought together doctors, medical professionals, and industry experts to discuss advancements in the timely diagnosis of breast cancer and patients' access to care.

This workshop was part of a strategic partnership between the privately held Hoan My Medical Group and its global partner Siemens Healthineers, seeking to leverage technological advancements to enhance healthcare standards for patients across Vietnam.

Breast cancer is the most common cancer globally, and according to the World Health Organization, rates are increasing – especially in developing countries. Here in Vietnam, there are over 34 reported cases of female breast cancer for every 100,000 women.

That makes it the most common form of cancer among women and the third-highest cause of female mortality. Therefore, prioritising the early screening and diagnosis of breast cancer is of the utmost importance to enhance the efficacy of preventative measures and treatments – and thus, improve patient survival rates.

Speaking at the event on advancing access to breast cancer care and early diagnosis, Siemens Healthineers showcased its comprehensive approach, Breast Health 360°, a customised range of solutions that covers all stages of breast health.

This healthcare journey encompasses a broad spectrum of services, including continuous medical history monitoring, screening, prompt detection, diagnostics and treatment choices, ongoing treatment and progress tracking, and post-treatment care and recovery.

As a result, patients receive comprehensive care of the highest level, from screening and diagnosis right through to rehabilitation and recovery.

During the workshop, Siemens Healthineers and Hoan My shared updates about innovations in digital mammography, including a 50 degree wide-angle Tomosynthesis and PRIME technology aimed at reducing the radiation administered to patients.

The 50 degree wide-angle Tomosynthesis enables the digital mammography system to adapt the compression force to optimise patient comfort during their scan.

At the same time, PRIME technology contributes to a reduction of up to 30 per cent in radiation dosage, all while maintaining consistent image quality. These advancements enhance both screening and day-to-day diagnostic procedures.

Dilshaad Ali Bin Abas Ali, CEO of Hoan My Medical Group said, “Early screening and diagnosis play an important role in the treatment of cancer, particularly breast cancer among women. Therefore, comprehensive management solutions and modern technology are vital to increase the efficiency of treatment and reduce the burden on patients.”

“By strengthening our cooperation with Siemens Healthineers, we will establish Centres of Excellence for cancer diagnosis and treatment to provide the best specialist care for patients in Vietnam,” Ali continued.

The breast cancer workshop is the latest stage of the long-term strategic partnership between Hoan My and Siemens Healthineers. This collaboration will ensure that patients in Thu Duc International General Hospital, as well as those in Hoan My’s 13 other hospitals and seven clinics, will benefit from the latest medical technologies and the best clinical outcomes in breast cancer, cardiology, and other specialities.

Through this strategic partnership, Hoan My is set to drive excellence across its network, delivering care that comes from the heart to patients throughout Vietnam.

Hoan My Medical Group launches Prima Medical Centre On May 15, Hoan My Medical Group launched Prima, a new premium medical centre, to position itself as a healthcare navigator for complete wellbeing solutions based on a personalised experience.

Lung cancer screening saves lives in Vietnam and Asia Early diagnosis through improved screening access and changes to how people are screened is critical to reduce lung cancer deaths in Vietnam and Asia, an area that bears the greatest burden from the disease, according to a new consensus by 19 experts from across Asia, published in the Journal of Thoracic Oncology.

Roche commitment to improving women’s cancer care Lennor Carrillo, general director of Roche Pharma Vietnam, and Dr. Qadeer Raza, general manager of Roche Vietnam (Diagnostics), spoke with VIR's Thanh Van about the latest report of women's cancer and reiterated their commitment to women’s cancer care with their combined strength of diagnostics and pharmaceuticals.